3rd Quarter - Report — HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY (2010)

Firm

HEALTHCARE INSTITUTE OF NEW JERSEY

Client

HEALTHCARE INSTITUTE OF NEW JERSEY

Income

—

Expenses

$106,162

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

promoting awareness of the biopharmaceutical and medical technology sectors promoting awareness of medical devices and their regulatory pathway through the FDA Promoting the prevention of health care associated infections through value based purchasing programs in CMS.

Lobbyist	Covered position, as disclosed
JOHN DUTHIE	—
STEVE ISSENMAN	Congressional Page 1989-1990
SARAH G KAN	Congressional Aid 1999-2002

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

promoting the research and development tax credit HR 6165 Life Sciences Investment Act

Lobbyist	Covered position, as disclosed
SARAH G KAN	Congressional Aid 1999 - 2002

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 6165 (111th)

Copyright/Patent/Trademark CPT

S.515 The Patent Reform Act of 2009

Lobbyist	Covered position, as disclosed
JOHN DUTHIE New	—
SARAH G KAN	Congressional Aid 1999 - 2002

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.